Literature DB >> 4547125

A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin.

B U Wintroub, E J Goetzl, K F Austen.   

Abstract

A biologically active neutral peptide mediator is cleaved from a plasma protein substrate by an alpha-1-antitrypsin-inhibitable serine protease apparently residing on the membrane of the human neutrophil. The peptide mediator has an approximate mol wt of 1,000, and is distinguished from the kinin peptides by a neutral isoelectric point, susceptibility to inactivation by trypsin as well as chymotrypsin and activity on the isolated, atropinized, and antihistamine-treated guinea pig ileum with relatively little action on the estrous rat uterus. The neutrophil protease is fully inhibitable by DFP, trypsin inhibitors from lima or soy bean, and alpha-1-antitrypsin and is associated with the high mol wt fragments of the neutrophil and not the nuclear, lysosomal, or cytoplasmic subcellular fraction. The substrate has an approximate mol wt of 90,000 and is chromatographically separable from kininogen. The exquisite sensitivity of the neutrophil protease to alpha-1-antitrypsin was established both by inhibition with highly purified alpha-1-antitrypsin and by the inability of the protease to generate detectable neutral peptide in a homozygous (ZZ) alpha-1-antitrypsin-deficient patient without heat inactivation of the residual inhibitor. On the other hand, plasma from a (null) alpha-1-antitrypsin-deficient patient supported neutral peptide generation and revealed an additional factor which inactivated neutral peptide.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4547125      PMCID: PMC2139623          DOI: 10.1084/jem.140.3.812

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  A micromethod for determination of bradykininogen under several conditions.

Authors:  C R DINIZ; I F CARVALHO
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

2.  The inhibition of plasmin by toxic phosphorus compounds.

Authors:  L A MOUNTER; B A SHIPLEY
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

3.  Serum 5-nucleotidase.

Authors:  T F DIXON; M PURDOM
Journal:  J Clin Pathol       Date:  1954-11       Impact factor: 3.411

4.  Demonstration of a kinin-generating enzyme in the lysosomes of human polymorphonuclear leukocytes.

Authors:  H Z Movat; S G Steinberg; F M Habal; N S Ranadive
Journal:  Lab Invest       Date:  1973-12       Impact factor: 5.662

5.  Hereditary alpha-1-antitrypsin deficiency.

Authors:  R C Talamo; J D Allen; M G Kahan; K F Auste
Journal:  N Engl J Med       Date:  1968-02-15       Impact factor: 91.245

6.  Neutral leucocyte proteases and elastase inhibited by plasma alpha 1 -antitrypsin.

Authors:  K Ohlsson
Journal:  Scand J Clin Lab Invest       Date:  1971-11       Impact factor: 1.713

7.  The kinin-forming and kininase activities of rabbit polymorphonuclear leucocytes.

Authors:  L M Greenbaum; K S Kim
Journal:  Br J Pharmacol Chemother       Date:  1967-02

8.  Inhibition of human granulocyte elastase by serum alpha-1-antitrypsin.

Authors:  A Janoff
Journal:  Am Rev Respir Dis       Date:  1972-01

9.  Plasma inhibitors of the components of the fibrinolytic pathway in man.

Authors:  A D Schreiber; A P Kaplan; K F Austen
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

10.  Distribution of lysosomal enzymes, cationic proteins, and bactericidal substances in subcellular fractions of human polymorphonuclear leukocytes.

Authors:  I R Welsh; J K Spitznagel
Journal:  Infect Immun       Date:  1971-08       Impact factor: 3.441

  10 in total
  16 in total

Review 1.  Role of granulocytes in immune complex-induced tissue injuries.

Authors:  C G Cochrane
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

2.  A neutrophil-dependent pathway for the generation of a neutral peptide mediator. II. Subcellular localization of the neutrophil protease.

Authors:  B U Wintroub; E J Goetzl; K F Austen
Journal:  Immunology       Date:  1977-07       Impact factor: 7.397

3.  Membrane endopeptidases of human neutrophil.

Authors:  M F Tsan; M S Jiang
Journal:  Inflammation       Date:  1985-06       Impact factor: 4.092

4.  Generation of histamine-releasing activity from serum albumin by medium derived from stimulated neutrophils of rat.

Authors:  D E Cochrane; W Boucher; R E Carraway
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

Review 5.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

6.  Confirmation of direct angiotensin formation by kallikrein.

Authors:  H Maruta; K Arakawa
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

7.  Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization.

Authors:  H H Newball; R W Berninger; R C Talamo; L M Lichtenstein
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

8.  Purification and characterization of a human neutrophil neutral protease. The neutral peptide-generating protease.

Authors:  J S Coblyn; K F Austen; B U Wintroub
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

9.  Identification of a human neutrophil angiotension II-generating protease as cathepsin G.

Authors:  M G Tonnesen; M S Klempner; K F Austen; B U Wintroub
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

10.  Neutral protease activation of peritoneal macrophage prostaglandin synthesis.

Authors:  J Chang; F Wigley; D Newcombe
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.